Personalised medicine

Biomarkers: What can they tell us?

Biomarkers are biochemical features or facets that can be used to measure the progress of disease or the effects of treatment.

CHD symptoms

Coronary heart disease (CHD) symptoms, presented in the context of a stressful life event, were identified as psychogenic when presented by women and organic when presented by men, which could help explain why there is often a delay in the assessment of women with CHD, according to research presented at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) conference.

'Individualised' healthcare services

Germans want a different healthcare system. 93% want individualised services — and they are prepared to pay for them, according to a study relating to the strategies of providers in Germany's healthcare system and their acceptance by the public.

The joint AACC/AACB conference

The American Association for Clinical Chemistry (AACC) and the Australasian Association of Clinical Biochemists (AACB) are joining together for the second time for a conference on major changes facing laboratorians in coming years, under the banner Laboratory Medicine - Into the Future.

Better treatment by computer-based decisions?

The US Agency for Healthcare Research and Quality (AHRQ) will fund a new project to develop four computer-based decision-tools that will help clinicians and patients answering questions like: When to use genetic tests? How to deal with the results? Or which treatment could be the best?

Deadline for hypoxic tumors

Moving personalized medicine from promise to practice. Siemens Healthcare announces the early study findings of a new imaging biomarker for hypoxic tumors. This clinically problematic cells tend to be less responsive to standard treatment regimens. A probe that measures hypoxia could prove quite a useful tool for oncologists.

Personalise healthcare!

The Old Dominion University in Virginia and Regensburg University Medical Center in Germany are jointly organizing an international conference to discuss recent advances and strategic needs in personalised healthcare (pHealth) care and to foster collaboration between industry and academia.

A scales to have faith in

The seca 959, a chair scale, has been designed by seca gmbh & co. kg, Hamburg, Germany, with input from experts, to accommodate patients with mobility or other problems. It is not only easy for patients and nurses to use, but, as the firm explains, ` practically eliminates body contact, which patients of Islamic faith in particular find unpleasant and try to avoid.´

Young woman underrepresented in breast cancer studies

More than 250,000 women under the age of forty are living with the disease in the US and 11,000 will be diagnosed in the next year. Even so, young women are underrepresented in many research studies and treatments, according to genomic expert Simon Chin.

In vitro diagonstics market boosted by new technologies

The future of the in vitro diagnostics (IVD) market looks promising. According to a new analysis from Frost & Sullivan, Western European IVD Market is estimated to reach $12.65 billion in 2014. The reason: Diseases depending on an aging population, such as infections, hike the demand for automated diagnostic tools.

Computer programme aims to personalise medicine

A computer programme under development at the National Centre for Biomolecular Research at Masaryk University, in Brno, by Jiri Damborsky MD and a team of scientists, could become the first step towards personalised medicine.

Personalised medicine?

'How do you treat the HIV-positive, diabetic, schizophrenic patient presenting with chest pain? By making the necessary information available for personalised medicine'

A new, multi-purpose interactive multimedia system

Currently used in pilot projects in the UK and the Netherlands, the new CareServant system from Philips, is an interactive multimedia system for use by hospital patients as well as staff.

Automated urinalysis systems

Roche's product portfolio includes three systems for urinary diagnostics, all of which use the proven Combur test strips.

Hippocrates meets Medusa's head

By Dr J Larsen MD FRCR, Consultant Radiologist at Braunschweig Hospital, Germany

analytica comes of age

21st. Analytica 2008 held in april 2008 in Munich, Germany.

Are New Techniques Needed in Modern Sonography?

Breast cancer is the most frequently occurring malignant tumour worldwide. Of the more than one million newly diagnosed cases each year, the incidence among women in Germany alone is more than 50,000. That means that every tenth woman is stricken by breast cancer at some point in her life. It numbers among the most frequent causes of death by cancer 1,2,3 , with the average age of onset being…

Chinese traditional medicine - a complement, not an alternative

The interest in using traditional Chinese medicine (TCM) alongside conventional Western medical care has steadily increased among European physicians; it is no longer unusual, for example, for acupuncture to be suggested by a doctor to help fight tobacco addiction, or to ease a persistent musculoskeletal problem.

A promising outlook for new gentle breast cancer therapies

Targeted medication and gentle surgical procedures are the pillars of modern breast cancer therapy, according to participants at this years German Congress of Senology.

Discovered: a new genetic route to skin cancer

UK - A complex chain of molecular triggers involved in the development of malignant melanoma has been unravelled

Asthma - Bavaria's novel care programme for youngsters

Thousands of children are hospitalised annually due to acute asthma attack. Special treatment, adapted to their individual needs, could prevent such emergencies.

The advent of personalised therapies

12 distinguished researchers and industry representatives presented the latest molecular medicine research at the Molecular Medicine - from Diagnostics to Therapy symposium - one in a series of annual diagnostics seminars organised by the Forum Medicine Technology & Pharmaceutics e.V.